Cognitive impairment in chronic heart failure. How new therapeutic options for the treatment of chronic heart failure affect cognitive function?

Heart failure is a serious chronic illness and a global healthcare problem. Patients with heart failure have increased hospital readmission rates and mortality around the world. Heart failure often coexists with comorbidities of which cognitive impairment is particularly important. Сognitive impairment is present in around 30% to 80% in heart failure decreases quality of life and increases the frequency of repeated hospitalizations, increases mortality and worsens the prognosis in such patients. Despite existing research, the underlying pathophysiology of the relationship between heart failure and cognitive impairment remains poorly understood. The article discusses the best available evidence concerning different pathophysiological mechanisms behind cognitive impairment in individuals with heart failure. Heart failure and cognitive impairment have a number of common pathophysiological pathways including reduced cerebral blood flow, inflammation, neurohumoral activations, oxidative stress and changes in serum biomarkers or proteins. Understanding the pathophysiology of diseases will allow the effective evaluation of health status and development of suitable treatments. Prompt detection of cognitive impairment will bring about better clinical outcomes in heart failure patients. This review raises questions about the relationship between heart failure and cognitive dysfunction, provides evidence on the impact of new therapeutic options for treating heart failure on cognitive function, and suggests potential future research directions. For example, implantation of an artificial left ventricle may improve cognitive function; however, there are studies on immediate improvement in cognitive function followed by gradual deterioration over time after implantation of an artificial left ventricle, which requires long-term study In addition, evidence is provided for the effectiveness of using a relaxation scenario in virtual reality technology to reduce anxiety and affective complaints in somatic hospitalized patients, but the ability to improve cognitive function in patients with chronic heart failure remains to be explored.

1. Groenewegen A., Rutten F.H., Mosterd A., Hoes A.W. Epidemiology of heart failure. Eur J Heart Fail. 2020;22(8):1342-1356. https://doi.org/10.1002/ejhf.1858

2. Bueno H., Moura B., Lancellotti P., Bauersachs J. The year in cardiovascular medicine 2020: heart failure and cardiomyopathies. Eur Heart J. 2021;42(6):657-670. https://doi.org/10.1093/eurheartj/ehaa1061

3. Fomin I.V. Chronic heart failure in Russian Federation: what do we know and what to do. Russian Journal of Cardiology. 2016;(8):7–13. https://doi.org/10.15829/1560-4071-2016-8-7-13

4. Dharmarajan K., Hsieh A.F., Kulkarni V.T. et al. Trajectories of risk after hospitalization for heart failure, acute myocardial infarction, or pneumonia: retrospective cohort study. BMJ. 2015;350:h411. https://doi.org/10.1136/bmj.h411

5. Connors E.J., Hauson A.O., Barlet B.D. et al. Neuropsychological Assessment and Screening in Heart Failure: A Meta-Analysis and Systematic Review. Neuropsychol. Rev. 2021;31(2):312-330. https://doi.org/10.1007/s11065-020-09463-3

6. Havakuk O., King K.S., Grazette L. et al. Heart failure-induced brain injury. J Am Coll Cardiol. 2017;69(12):1609-1616. https://doi.org/10.1016/j.jacc.2017.01.022

7. Dunne R.A., Aarsland D., O'Brien J.T. et al. Mild cognitive impairment: the Manchester consensus. Age Ageing. 2021;50(1):72-80. https://doi.org/10.1093/ageing/afaa228

8. Dardiotis E., Giamouzis G., Mastrogiannis D., Vogiatzi C., Skoularigis J., Triposkiadis F., Hadjigeorgiou G.M. Cognitive impairment in heart failure. Cardiol Res Pract. 2012;595821. https://doi.org/10.1155/2012/595821

9. Yang M., Sun D., Wang Y., Yan M., Zheng J., Ren J. (2022). Cognitive impairment in heart failure: Landscape, challenges, and future directions. Front. Cardiovasc. Med. 2022; 8:831734. https://doi.org/10.3389/fcvm.2021.831734

10. Holm H., Bachus E., Jujic A., Nilsson E.D., Wadström B., Molvin J., Minthon L., Fedorowski A., Nägga K., Magnusson M. Cognitive test results are associated with mortality and rehospitalization in heart failure: Swedish prospective cohort study. ESC Heart Failure. 2020;7(5):2948–2955. https://doi.org/10.1002/ehf2.12909

11. Sam R.S.N., Mohamed Raffi H.Q. and Dong Y. The pathophysiology of cognitive impairment in individuals with heart failure: a systematic review. Front Cardiovasc Med. 2023;10:1181979. https://doi.org/10.3389/fcvm.2023.1181979

12. Dong Y., Teo S.Y., Kang K. et al. Cognitive impairment in Asian patients with heart failure: prevalence, biomarkers, clinical correlates, and outcomes. Eur J Heart Fail. 2019;21(5):688-690. https://doi.org/10.1002/ejhf.1442

13. Li T., Bao X., Li L., Qin R., Li C. and Wang X. Heart failure and cognitive impairment: A narrative review of neuroimaging mechanism from the perspective of brain MRI. Front Neurosci. 2023;17:1148400. https://doi.org/10.3389/fnins.2023.1148400

14. Miao F., Wang B., Zhang L. et al. Distinct Associations Between Postdischarge Cognitive Change Patterns and 1-year Outcomes in Patients Hospitalized for Heart Failure. Journal of Cardiac Failure. 2023;870-879. https://doi.org/10.1016/j.cardfail.2023.01.006

15. Ampadu J., Morley J.E. Heart failure and cognitive dysfunction. Int J Cardiol. 2015;178:12–23. https://doi.org/10.1016/j.ijcard.2014.10.087

16. Frey A., Sell R., Homola G.A. et al. Cognitive deficits and related brain lesions in patients with chronic heart failure. JACC Heart Fail. 2018;6(7):583-592. https://doi.org/10.1016/j.jchf.2018.03.010

17. Ichijo Y., Kono S., Yoshihisa A. et al. Impaired frontal brain activity in patients with heart failure assessed by near-infrared spectroscopy. Journal of the American Heart Association. 2020;9:e014564. https://doi.org/10.1161/JAHA.119.014564

18. Warraich H.J., Kitzman D.W., Whellan D.J. et al. Physical function, frailty, cognition, depression, and quality of life in hospitalized adults ≥60 years with acute decompensated heart failure with preserved versus reduced ejection fraction. Circulation: Heart Failure. 2018;11:e005254. https://doi.org/10.1161/CIRCHEARTFAILURE.118.005254

19. Hammond C.A., Blades N.J., Chaudhry S.I. et al. Long-Term Cognitive Decline After Newly Diagnosed Heart Failure: Longitudinal Analysis in the CHS (Cardiovascular Health Study). Circulation: Heart Failure. 2018;11:e004476. https://doi.org/10.1161/CIRCHEARTFAILURE.117.004476

20. Saito H., Yamashita M., Endo Y. et al. Cognitive impairment measured by Mini-Cog provides additive prognostic information in elderly patients with heart failure. J Cardiol. 2020;76(4):350-356. https://doi.org/10.1016/j.jjcc.2020.06.016

21. Lee T.C., Qian M., Liu Y. et al. Cognitive Decline Over Time in Patients with Systolic Heart Failure: Insights From WARCEF. JACC Heart Fail. 2019;7:1042–1053. https://doi.org/10.1016/j.jchf.2019.09.003

22. Ren Z. Effects of Chronic Heart Failure on Longitudinal Changes of Cognitive Function in Elderly Patients. Contrast Media Mol Imaging. 2022;23:9871800. https://doi.org/10.1155/2022/9871800

23. Sacre J.W., Ball J., Wong C. et al. Mild cognitive impairment is associated with subclinical diastolic dysfunction in patients with chronic heart disease. Eur Heart J Cardiovasc Imaging. 2018;19(3):285-292. https://doi.org/10.1093/ehjci/jex169

24. Matsue Y., Kamiya K., Saito H. et al. Prevalence and prognostic impact of the coexistence of multiple frailty domains in elderly patients with heart failure: the FRAGILE-HF cohort study. Eur J Heart Fail. 2020;22(11):2112-2119. https://doi.org/10.1002/ejhf.1926

25. Kure C.E., Rosenfeldt F.L., Scholey A.B. et al. Relationships among cognitive function and cerebral blood flow, oxidative stress, and inflammation in older heart failure patients. J Card Fail. 2016;22(7):548- 59. https://doi.org/10.1016/j.cardfail.2016.03.006

26. Huynh Q.L., Whitmore K., Negishi K. et al. Cognitive impairment as a determinant of response to management plans after heart failure admission. Eur J Heart Fail. 2021;23(7):1205-1214. https://doi.org/10.1002/ejhf.2177

27. Vellone E., Chialà O., Boyne J. et al. Cognitive impairment in patients with heart failure: an international study. ESC Heart Fail. 2020;7(1):46- 53. https://doi.org/10.1002/ehf2.12542

28. Ovsenik A., Podbregar M., Fabjan A. Сerebral blood flow impairment and cognitive decline in heart failure. Brain Behav. 2021;11(6):e02176. https://doi.org/10.1002/brb3.2176

29. Vogels, R.L., Oosterman, J.M., van Harten, B. et al. Neuroimaging and correlates of cognitive function among patients with heart failure. Dementia and Geriatric Cognitive Disorders. 2007;24(6):418-23. https://doi.org/10.1159/000109811

30. Sabayan B., van Buchem M., Sigurdsson S. et al. Cardiac hemodynamics are linked with structural and functional features of brain aging: The age, gene/environment susceptibility (AGES)-Reykjavik Study. Journal of the American Heart Association. 2015;4(1):e001294. https://doi.org/10.1161/JAHA.114.001294

31. Meguro T., Meguro Y., Kunieda T. Atrophy of the parahippocampal gyrus is prominent in heart failure patients without dementia. ESC Heart Fail. 2017; 4(4):632-640. https://doi.org/10.1002/ehf2.12192

32. Caldas J.R., Panerai R.B., Haunton V.J. Cerebral blood flow in ischemic heart failure. American Journal of Regulatory, Integrative and Comparative Physiology. 2017;312(1):R108–R113. https://doi.org/10.1152/ajpregu.00361.2016

33. Kim J.H., Shah P., Tantry U.S. et al. Coagulation abnormalities in heart failure: Pathophysiology and therapeutic implications. Curr. Heart Fail. Rep. 2016;13(6):319-328. https://doi.org/10.1007/s11897-016-0308-6

34. Toledo C., Andrade D.C., Díaz H.S., Inestrosa N.C., Del Rio R. Neurocognitive disorders in heart failure: novel pathophysiological mechanisms underpinning memory loss and learning impairment. Mol Neurobiol. 2019;56(12):8035-8051. https://doi.org/10.1007/s12035-019-01655-0

35. Iadecola, C. The neurovascular unit coming of age: A journey through neurovascular coupling in health and disease. Neuron. 2017;96(1):17- 42. https://doi.org/10.1016/j.neuron.2017.07.030

36. Athilingam P., Moynihan J., Chen L., D'Aoust R., Groer M., Kip K. Elevated levels of interleukin 6 and C-reactive protein associated with cognitive impairment in heart failure. Congest Heart Fail. 2013;19(2):92-8. https://doi.org/10.1111/chf.12007

37. Gonzalez P., Machado I., Vilcaes A. et al. Molecular mechanisms involved in interleukin 1-beta (IL-1β)-induced memory impairment Modulation by alpha-melanocyte-stimulating hormone (α-MSH). Brain Behav Immun. 2013;34:141-50. https://doi.org/10.1016/j.bbi.2013.08.007

38. Gardarsdottir, M., Sigurdsson, S., Aspelund, T. et al. Atrial fibrillation is associated with decreased total cerebral blood flow and brain perfusion. Europace. 2018;20(8):1252-1258. https://doi.org/10.1093/europace/eux220

39. Saglietto, A., Scarsoglio, S., Ridolfi, L., Gaita, F., & Anselmino, M. Higher ventricular rate during atrial fibrillation relates to increased cerebral hypoperfusions and hypertensive events. Scientific Reports. 2019;9,3779. https://doi.org/10.1038/s41598-019-40445-5

40. Kalaria V.G., Passannante M.R., Shah T., Modi K., Weisse A.B. Effect of mitral regurgitation on left ventricular thrombus formation in dilated cardiomyopathy. Am. Hear. J. 1998;135:215–220. https://doi.org/10.1016/S0002-8703(98)70084-5

41. Freudenberger R.S., Hellkamp A.S., Halperin J.L., Poole J., Anderson J., Johnson G., Mark D.B., Lee K.L., Bardy G.H. Risk of thromboembolism in heart failure: An analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Circulation. 2007;115(20):2637-41. https://doi.org/10.1161/CIRCULATIONAHA.106.661397

42. Mehra M.R., Cleveland J.C., Uriel N. et al. Primary results of long-term outcomes in the MOMENTUM 3 pivotal trial and continued access protocol study phase: a study of 2200 HeartMate 3 left ventricular assist device implants. Randomized Controlled Trial. Eur J Heart Fail. 2021;23(8):1392-1400. https://doi.org/10.1002/ejhf.2211

43. Zimpfer D., Wieselthaler G., Czerny M. et al. Neurocognitive function in patients with ventricular assist devices: a comparison of pulsatile and continuous blood flow devices. ASAIO J. 2006;52(1):24–27. https://doi.org/10.1097/01.mat.0000191334.51375.7e

44. Pavol M.A., Willey J.Z., Wei Y. et al. Does cognition improve following LVAD implantation? Gen Thorac Cardiovasc Surg. 2018;66(8):456- 463. https://doi.org/10.1007/s11748-018-0947-5

45. Bhat G., Yost G., Mahoney E. Cognitive function and left ventricular assist device implantation. J Heart Lung Transplant. 2015;34(11):1398- 405. https://doi.org/10.1016/j.healun.2015.05.015

46. Cornwell, W.K. 3rd, Tarumi, T., Aengevaeren, V.L. et al. Effect of pulsatile and nonpulsatile flow on cerebral perfusion in patients with left ventricular assist devices. The Journal of Heart and Lung Transplantation. 2014;33(12):1295-303. https://doi.org/10.1016/j.healun.2014.08.013

47. Stohr, E.J., McDonnell, B.J., Colombo, P. C., & Willey, J. Z. CrossTalk proposal: Blood flow pulsatility in left ventricular assist device patients is essential to maintain normal brain physiology. The Journal of Physiology. 2019;(2):353-356. https://doi.org/10.1113/JP276729

48. Cho S.M., Floden D., Wallace K. et al. Long-Term Neurocognitive Outcome in Patients With Continuous Flow Left Ventricular Assist Device. JACC Heart Fail. 2021;9(11)839–851. https://doi.org/10.1016/j. jchf.2021.05.016

49. Jung M, Apostolova LG, Moser DK, Gradus-Pizlo I, Gao S, Rogers JL, Pressler SJ. Virtual reality cognitive intervention for heart failure: CORE study protocol. Alzheimers Dement (N Y). 2022;8(1):e12230. https://doi.org/10.1002/trc2.12230

50. Lepilkina TA, Beniashvili АG, Cheremin RА, Malyukova NG, Morozova MA, Bogdanov MA, Burminskiy DS, Potanin SS, Rodkina SV, Rupchev GE, Eip MN. Efficacy of a relaxation scenario in virtual reality for comorbid symptoms of anxiety and asthenia in a general hospital setting: a pilot comparative randomized open-label study. Consortium Psychiatricum. 2023;4(1):CP221. https://doi.org/10.17816/CP221